Literature DB >> 22065307

Presence of an interaction between smoking and being overweight increases risks of hypertension, diabetes, and cardiovascular disease in outpatients with mood disorders.

Midori Nishiyama1, Michio Kimijima, Takashi Muto, Kazumoto Kimura.   

Abstract

OBJECTIVE: We aimed to evaluate the hypothesis that the presence of an interaction between smoking and being overweight increases the risks of lifestyle-related diseases (hypertension, diabetes mellitus, dyslipidemia, and cardiovascular disease) in outpatients with mood disorders.
METHODS: In this cross-sectional survey, using data from 213 outpatients with mood disorders (95 men, 118 women), we calculated the adjusted odds ratios (ORs) with 95% confidence intervals (CIs) for each of hypertension, diabetes, dyslipedemia, and cardiovascular disease, using a binary logistic regression model; we then calculated the adjusted OR values for smokers and non-smokers with body mass indexes (BMIs) of <25 or ≥25 kg/m². Next, we examined the data for the presence of an interaction between smoking and being overweight, using three measures of additive interaction: relative excess risk due to the interaction (RERI), attributable proportion due to the interaction (AP), and the synergy index (S).
RESULTS: Smokers with BMI <25 kg/m² had a significantly lower risk of hypertension (OR 0.27, 95% CI 0.09-0.81) than non-smokers with BMI <25 kg/m² (reference group). Compared with the reference group, overweight non-smokers had a significantly higher risk (2.82, 1.34-6.19) of hypertension, and overweight smokers had a higher risk (4.43, 1.28-15.26) of hypertension and very high risks of diabetes (8.24, 2.47-27.42) and cardiovascular disease (13.12, 1.95-88.41). The highest RERI was derived from the relation with cardiovascular disease. The highest AP and S were derived from the relation with type 2 diabetes. There was no interaction of smoking and being overweight with dyslipidemia.
CONCLUSION: The presence of an interaction between smoking and being overweight exacerbates the risks of hypertension, diabetes, and cardiovascular disease in outpatients with mood disorders.

Entities:  

Mesh:

Year:  2011        PMID: 22065307      PMCID: PMC3390563          DOI: 10.1007/s12199-011-0250-x

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  32 in total

1.  The acceptability of physical activity programming within a smoking cessation service for individuals with severe mental illness.

Authors:  Guy Faulkner; Adrian Taylor; Shelly Munro; Peter Selby; Chris Gee
Journal:  Patient Educ Couns       Date:  2006-12-20

2.  The effects of physical activity in the acute treatment of bipolar disorder: a pilot study.

Authors:  Felicity Ng; Seetal Dodd; Michael Berk
Journal:  J Affect Disord       Date:  2006-12-19       Impact factor: 4.839

3.  Excess mortality in bipolar and unipolar disorder in Sweden.

Authors:  U Osby; L Brandt; N Correia; A Ekbom; P Sparén
Journal:  Arch Gen Psychiatry       Date:  2001-09

4.  Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis.

Authors:  Jürgen Barth; Martina Schumacher; Christoph Herrmann-Lingen
Journal:  Psychosom Med       Date:  2004 Nov-Dec       Impact factor: 4.312

5.  Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients.

Authors:  F Cassidy; E Ahearn; B J Carroll
Journal:  Am J Psychiatry       Date:  1999-09       Impact factor: 18.112

6.  Depressive mood accompanies hypercholesterolemia in young Japanese adults.

Authors:  M Nakao; K Ando; S Nomura; T Kuboki; Y Uehara; T Toyooka; T Fujita
Journal:  Jpn Heart J       Date:  2001-11

7.  2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension.

Authors:  Judith A Whitworth
Journal:  J Hypertens       Date:  2003-11       Impact factor: 4.844

8.  Depressive symptoms predict 12-month prognosis in elderly patients with acute myocardial infarction.

Authors:  Issei Shiotani; Hiroshi Sato; Kunihiro Kinjo; Daisaku Nakatani; Hiroya Mizuno; Yozo Ohnishi; Eiji Hishida; Yoshiyuki Kijima; Masatsugu Hori; Hideyuki Sato
Journal:  J Cardiovasc Risk       Date:  2002-06

Review 9.  Excess mortality of mental disorder.

Authors:  E C Harris; B Barraclough
Journal:  Br J Psychiatry       Date:  1998-07       Impact factor: 9.319

10.  Smoking among psychiatric outpatients: relationship to substance use, diagnosis, and illness severity.

Authors:  Peter A Vanable; Michael P Carey; Kate B Carey; Stephen A Maisto
Journal:  Psychol Addict Behav       Date:  2003-12
View more
  5 in total

1.  Relationship Between Hematocrit Level and Cardiovascular Risk Factors in a Community-Based Population.

Authors:  Yuan-Ze Jin; Dong-Han Zheng; Zhi-Ying Duan; Ying-Zi Lin; Xue-Ying Zhang; Jing-Ru Wang; Shuo Han; Guo-Feng Wang; Yi-Jing Zhang
Journal:  J Clin Lab Anal       Date:  2014-05-21       Impact factor: 2.352

2.  Increased Level of Systolic Blood Pressure in Hepatocellular Carcinoma Patients with Diabetes Mellitus.

Authors:  Wei-Shuo Zhang; Xiao-Ou Li; Hui Zhang; Chun Gao; Long Fang; Hua-Yuan Yang
Journal:  Diabetes Metab Syndr Obes       Date:  2020-06-15       Impact factor: 3.168

3.  Joint Effect of Maternal Tobacco Smoking and Pregestational Diabetes on Preterm Births and Congenital Anomalies: A Population-Based Study in Northern Italy.

Authors:  Lucia Borsari; Carlotta Malagoli; Martha M Werler; Kenneth J Rothman; Marcella Malavolti; Rossella Rodolfi; Gianfranco De Girolamo; Fausto Nicolini; Marco Vinceti
Journal:  J Diabetes Res       Date:  2018-06-28       Impact factor: 4.011

4.  Elevated glycosylated hemoglobin levels and their interactive effects on hypertension risk in nondiabetic Chinese population: a cross-sectional survey.

Authors:  Jian Song; Nana Wei; Yingying Zhao; Yuhong Jiang; Xuesen Wu; Huaiquan Gao
Journal:  BMC Cardiovasc Disord       Date:  2020-05-12       Impact factor: 2.298

5.  The effects of the interaction between BMI and dyslipidemia on hypertension in adults.

Authors:  Na Tang; Jian Ma; Rongqin Tao; Zhijun Chen; Yide Yang; Quanyuan He; Yuan Lv; Zelong Lan; Junhua Zhou
Journal:  Sci Rep       Date:  2022-01-18       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.